Access the full text.
Sign up today, get DeepDyve free for 14 days.
In this meta-analysis, OST was associated with a 45% increase in odds of viral suppression, but there was limited evidence from six studies for OST decreasing mortality for PWID on ART
M. Kazatchkine (2014)
Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central AsiaJournal of the International AIDS Society, 17
S. Hermosilla, N. El-Bassel, A. Aifah, A. Terlikbayeva, Z. Zhumadilov, Kulzhan Berikkhanova, M. Darisheva, L. Gilbert, N. Schluger, S. Galea (2015)
Tuberculosis report among injection drug users and their partners in Kazakhstan.Public health, 129 5
A. Davis, Tara McCrimmon, A. Dasgupta, L. Gilbert, A. Terlikbayeva, T. Hunt, S. Primbetova, E. Wu, M. Darisheva, N. El-Bassel (2018)
Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.The International journal on drug policy, 62
Daniel Escudero, M. Lurie, T. Kerr, C. Howe, B. Marshall (2014)
HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future researchJournal of the International AIDS Society, 17
E. King, Kateryna Maksymenko, Y. Almodóvar-Díaz, Sarah Johnson (2016)
‘If she is a good woman …’ and ‘to be a real man …’: gender, risk and access to HIV services among key populations in TajikistanCulture, Health & Sexuality, 18
N. El-Bassel, S. Strathdee, W. Sadr (2013)
HIV and people who use drugs in central Asia: confronting the perfect storm.Drug and alcohol dependence, 132 Suppl 1
D. Jarlais, A. Boltaev, J. Feelemyer, Heidi Bramson, K. Arasteh, B. Phillips, H. Hagan (2013)
Gender disparities in HIV infection among persons who inject drugs in Central Asia: a systematic review and meta-analysis.Drug and alcohol dependence, 132 Suppl 1
(2017)
Novel psychoactive substances: policy. Economics and drug regulation
(2018)
to go: closing gaps, breaking barriers, fighting injustices
conducted a systematic review to examine the association of opioid agonist therapy with ART initiation among HIV-positive people who inject drugs (PWID)
W. Miller, I. Hoffman, B. Hanscom, T. Ha, Kostyantyn Dumchev, Z. Djoerban, S. Rose, C. Latkin, D. Metzger, K. Lancaster, V. Go, Sergii Dvoriak, K. Mollan, S. Reifeis, E. Piwowar-Manning, P. Richardson, M. Hudgens, Erica Hamilton, J. Sugarman, S. Eshleman, H. Susami, V. Chu, Samsuridjal Djauzi, T. Kiriazova, D. Bui, S. Strathdee, D. Burns (2018)
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyThe Lancet, 392
L. Lappalainen, S. Nolan, S. Dobrer, Cathy Puscas, Julio, Montaner, K. Ahamad, Huiru Dong, T. Kerr, E. Wood, M-J, Milloy (2015)
DOSE-RESPONSE RELATIONSHIP BETWEEN METHADONE DOSE AND ADHERENCE TO ANTIRETROVIRAL THERAPY AMONG HIV-POSITIVE PERSONS WHO USE ILLICIT OPIOIDS
S. Solomon, A. Mcfall, G. Lucas, A. Srikrishnan, M. Kumar, S. Anand, T. Quinn, D. Celentano, S. Mehta (2017)
Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysisPLoS Medicine, 14
A. Kamarulzaman, F. Altice (2015)
Challenges in managing HIV in people who use drugsCurrent Opinion in Infectious Diseases, 28
S. Springer, Angela Paola, M. Azar, R. Barbour, Breanne Biondi, Maureen Desabrais, T. Lincoln, D. Skiest, F. Altice (2018)
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 78
E. Williams, J. Hahn, R. Saitz, K. Bryant, M. Lira, J. Samet (2016)
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.Alcoholism, clinical and experimental research, 40 10
P. Smyrnov, L. Williams, A. Korobchuk, Y. Sazonova, G. Nikolopoulos, B. Skaathun, E. Morgan, J. Schneider, T. Vasylyeva, S. Friedman (2018)
Risk network approaches to locating undiagnosed HIV cases in Odessa, UkraineJournal of the International AIDS Society, 21
W. El-Sadr, Katherine Harripersaud, M. Rabkin (2017)
Reaching global HIV/AIDS goals: What got us here, won't get us therePLoS Medicine, 14
L. Mlunde, B. Sunguya, J. Mbwambo, O. Ubuguyu, J. Yasuoka, M. Jimba (2016)
Association of opioid agonist therapy with the initiation of antiretroviral therapy - a systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 46
(2019)
90–90–90 - an ambitious treatment target to help end the AIDS
T. Sandfort, J. Knox, C. Alcala, N. El-Bassel, I. Kuo, L. Smith (2017)
Substance Use and HIV Risk Among Men Who Have Sex With Men in Africa: A Systematic ReviewJAIDS Journal of Acquired Immune Deficiency Syndromes, 76
D. Jarlais, K. Arasteh, C. McKnight, J. Feelemyer, A. Campbell, S. Tross, H. Cooper, H. Hagan, D. Perlman (2017)
What happened to the HIV epidemic among non‐injecting drug users in New York City?Addiction, 112
Georgie MacArthur, S. Minozzi, N. Martin, P. Vickerman, S. Deren, J. Bruneau, L. Degenhardt, M. Hickman (2012)
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysisThe BMJ, 345
F. Altice, A. Kamarulzaman, V. Soriano, M. Schechter, G. Friedland (2010)
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugsThe Lancet, 376
Kenneth Harris, J. Arnsten, A. Litwin (2010)
Successful Integration of Hepatitis C Evaluation and Treatment Services With Methadone MaintenanceJournal of Addiction Medicine, 4
(2019)
Report 2018
B. Turan, A. Rogers, Whitney Rice, Ghislaine Atkins, Mardge Cohen, T. Wilson, A. Adimora, D. Merenstein, A. Adedimeji, Eryka Wentz, Ighovwhera Ofotokun, L. Metsch, P. Tien, Mallory Johnson, J. Turan, S. Weiser (2017)
Association between Perceived Discrimination in Healthcare Settings and HIV Medication Adherence: Mediating Psychosocial MechanismsAIDS and Behavior, 21
B. Norton, A. Beitin, M. Glenn, Joseph Deluca, Alain Litwin, C. Cunningham (2017)
Retention in buprenorphine treatment is associated with improved HCV care outcomes.Journal of substance abuse treatment, 75
M. Kan, Danielle Garfinkel, O. Samoylova, R. Gray, K. Little (2018)
Social network methods for HIV case‐finding among people who inject drugs in TajikistanJournal of the International AIDS Society, 21
Nga Vu, L. Maher, I. Zablotska (2015)
Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysisJournal of the International AIDS Society, 18
L. Azbel, Maxim Polonsky, M. Wegman, Natalya Shumskaya, A. Kurmanalieva, A. Asanov, Jeffrey Wickersham, Sergii Dvoriak, F. Altice (2016)
Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment.The International journal on drug policy, 37
L. Degenhardt, Bradley Mathers, M. Guarinieri, S. Panda, B. Phillips, S. Strathdee, M. Tyndall, L. Wiessing, A. Wodak, J. Howard (2010)
Meth/amphetamine use and associated HIV: Implications for global policy and public health.The International journal on drug policy, 21 5
L. Sordo, G. Barrio, M. Bravo, Iciar Indave, L. Degenhardt, L. Wiessing, M. Ferri, R. Pastor-Barriuso (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesThe BMJ, 357
J. Tucker, M. Orlando, Burnam Ma, C. Sherbourne, Kung Fy, A. Gifford (2004)
Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems.Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 23 4
A. Deryabina, P. Patnaik, W. El-Sadr (2019)
Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and KyrgyzstanHarm Reduction Journal, 16
A. Deryabina, W. El-Sadr (2017)
Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.Drug and alcohol dependence, 179
K. Choopanya, Michael Martin, P. Suntharasamai, Udomsak Sangkum, P. Mock, M. Leethochawalit, Sithisat Chiamwongpaet, Praphan Kitisin, Pitinan Natrujirote, Somyot Kittimunkong, R. Chuachoowong, R. Gvetadze, J. Mcnicholl, L. Paxton, M. Curlin, C. Hendrix, S. Vanichseni (2013)
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet, 381
U. Ibragimov, H. Cooper, R. Haardörfer, K. Dunkle, W. Zule, F. Wong (2017)
Stigmatization of people who inject drugs (PWID) by pharmacists in Tajikistan: sociocultural context and implications for a pharmacy-based prevention approachHarm Reduction Journal, 14
K. Biello, K. Biello, A. Bazzi, M. Mimiaga, D. Biancarelli, Alberto Edeza, P. Salhaney, E. Childs, M. Drainoni (2018)
Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugsHarm Reduction Journal, 15
(2018)
Lack of effective opioid dependence and alcohol abuse treatment leads to high rates of treatment discontinuation among patients initiated on antiretroviral therapy in Kazakhstan
T. Vasylyeva, Friedman, P. Smyrnov, K. Bondarenko (2015)
A new approach to prevent HIV transmission: Project Protect intervention for recently infected individualsAIDS Care, 27
This study provides evidence that a flexible, scalable intervention increases ART and MAT use and reduces mortality among PWID
S. Springer, Angela Paola, R. Barbour, M. Azar, F. Altice (2018)
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 79
Annika Johannson, S. Vorobjov, R. Heimer, J. Dovidio, A. Uusküla (2017)
The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, EstoniaAIDS and Behavior, 21
O. Morozova, Sergii Dvoryak, F. Altice (2013)
Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine.The International journal on drug policy, 24 6
(2011)
Mapping of key HIV services assessment of their quality and analysis of gaps and needs of most-at-risk populations in Chui oblast and Bishkek city Kyrgyzstan
A. Low, G. Mburu, N. Welton, M. May, C. Davies, C. French, K. Turner, K. Looker, H. Christensen, Susie McLean, T. Rhodes, L. Platt, M. Hickman, Andy Guise, P. Vickerman (2016)
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-AnalysisClinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 63
K. Lancaster, Angela Hetrick, A. Jaquet, A. Adedimeji, L. Atwoli, D. Colby, Á. Mayor, A. Parcesepe, J. Syvertsen (2018)
Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research prioritiesJournal of Virus Eradication, 4
A. Terlikbayeva, B. Zhussupov, S. Primbetova, L. Gilbert, Nurmat Atabekov, Gusal Giyasova, Murodali Ruziev, A. Soliev, D. Saliev, N. El-Bassel (2013)
Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care.Drug and alcohol dependence, 132 Suppl 1
(2016)
Is HIV self-testing acceptable to key populations in Vietnam? Results from a cross-sectional study of men who have sex with men, female sex workers and people who inject drugs
D. Jarlais, C. McKnight, K. Arasteh, J. Feelemyer, D. Perlman, H. Hagan, Emily Dauria, H. Cooper (2014)
A Perfect Storm: Crack Cocaine, HSV-2, and HIV Among Non-Injecting Drug Users in New York CitySubstance Use & Misuse, 49
Susan Cohn, Hongyu Jiang, J. McCutchan, S. Koletar, Robert Murphy, Kevin Robertson, Annabelle Maurice, Judith S. Currier, Paige Williams (2011)
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362AIDS Care, 23
(2017)
Improvement of treatment of drug use disorders in Central Asia the contribution of the EU Central Asia Drug Action Programme (CADAP)
R. Marcus, Iuliia Makarenko, Alyona Mazhnaya, Alexei Zelenev, Maxim Polonsky, Lynn Madden, S. Filippovych, Sergii Dvoriak, S. Springer, F. Altice (2017)
Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine.Drug and alcohol dependence, 179
G. Mburu, S. Ayón, A. Tsai, J. Ndimbii, Bangyuan Wang, S. Strathdee, J. Seeley (2018)
“Who has ever loved a drug addict? It’s a lie. They think a ‘teja’ is as bad person”: multiple stigmas faced by women who inject drugs in coastal KenyaHarm Reduction Journal, 15
K. Lancaster, Thandie Lungu, Pearson Mmodzi, M. Hosseinipour, Katy Chadwick, K. Powers, B. Pence, V. Go, I. Hoffman, W. Miller (2017)
The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, MalawiAIDS Care, 29
Yuehan Zhang, T. Wilson, A. Adedimeji, D. Merenstein, J. Milam, Jennifer Cohen, Mardge Cohen, E. Golub (2018)
The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United StatesAIDS and Behavior, 22
(2001)
United Nations Publication
B. Vu, K. Green, Huong Phan, Minh Tran, Huu Ngo, Son Vo, Trang Ngo, Anh Doan, An Bao, Linh Dang, Giang Ha (2018)
Lay provider HIV testing: A promising strategy to reach the undiagnosed key populations in VietnamPLoS ONE, 13
Alison BROWN1, Kathy Attawell, David Hales, Brian Rice, A. Pharris, Virginie Supervie, D. Beckhoven, Valerie Delpech, M. Heiden, Ulrich Marcus, Marek Maly, T. Noori, Alison Brown (2018)
Monitoring the HIV continuum of care in key populations across Europe and Central AsiaHIV Medicine, 19
H. Getahun, A. Baddeley, M. Raviglione (2013)
Managing tuberculosis in people who use and inject illicit drugs.Bulletin of the World Health Organization, 91 2
F. Altice, L. Azbel, J. Stone, E. Brooks-Pollock, P. Smyrnov, Sergii Dvoriak, F. Taxman, N. El-Bassel, N. Martin, R. Booth, Heino Stöver, K. Dolan, P. Vickerman (2016)
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central AsiaThe Lancet, 388
D. França, N. Del-Rios, M. Carneiro, R. Guimarães, K. Caetano, M. Reis, R. Martins, A. Motta-Castro, M. Stefani, S. Teles (2018)
HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristicsPLoS ONE, 13
Purpose of review To summarize the status of HIV and substance use in Central Asia and discuss potential ways to move forward to effective epidemic control among people who inject drugs (PWID) in the region and beyond. Recent findings PWID and their partners remain the population most affected by HIV in Central Asia. Lack of effective substance use prevention and treatment options and limited involvement of PWID-led community-based organizations in HIV programs, combined with the requirement for official registration, stigma and discrimination of PWID, and criminalization of drug use remain key barriers to effective HIV prevention and treatment. Summary Sustainable HIV epidemic control among PWID will not be feasible without decriminalization of drug use, addressing stigma and discrimination and policy changes to enhance uptake of HIV-related prevention, treatment and support services by PWID. It is also critical to ensure adoption of innovations, particularly those that combine evidence-based biomedical, behavioral and structural interventions tailored to the needs of the PWID. ICAP at Columbia University, Mailman School of Public Health, Columbia University, Almaty, Kazakhstan Correspondence to Anna P. Deryabina, 34/1 Samal -3, Almaty 050051, Kazakhstan. Tel: +7 727 2631572; e-mail: annaderyabina@icap.kz This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
Current Opinion in HIV and Aids – Wolters Kluwer Health
Published: Sep 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.